Matthias Eiber
Impact in
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 155
- Prostate Cancer Diagnosis and Treatment 95
-
- Radiopharmaceutical Chemistry and Applications 101
- Medical Imaging Techniques and Applications 22
- Radiomics and Machine Learning in Medical Imaging 10
- Co-authors
- Tobias Maurer (103 shared papers)Markus Schwaiger (71 shared papers)Jürgen E. Gschwend (54 shared papers)Hans‐Jürgen Wester (27 shared papers)Isabel Rauscher (38 shared papers)Ambros J. Beer (32 shared papers)Michael Souvatzoglou (30 shared papers)Bernhard Haller (18 shared papers)
- Journals
- Journal of Nuclear Medicine (36 papers)European Journal of Nuclear Medicine and Molecular Imaging (19 papers)EJNMMI Research (8 papers)European Urology (8 papers)The Journal of Urology (6 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Matthias Eiber
183 papers receiving 10.7k citations
Matthias Eiber's Hit Papers
Peers
Comparison fields: 5 of 111
- Radiology, Nuclear Medicine and Imaging 6.8k
- Pulmonary and Respiratory Medicine 8.9k
- Rheumatology 1.3k
- Oncology 2.1k
- Cancer Research 1.0k
Countries citing papers authored by Matthias Eiber
This map shows the geographic impact of Matthias Eiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Eiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Eiber more than expected).
Fields of papers citing papers by Matthias Eiber
This network shows the impact of papers produced by Matthias Eiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Eiber. The network helps show where Matthias Eiber may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthias Eiber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy Hit paper breakdown → | 2015 | 813 |
| 2 | Diagnostic Efficacy of 68 Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer Hit paper breakdown → | 2015 | 595 |
| 3 | 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 Hit paper breakdown → | 2017 | 567 |
| 4 | Current use of PSMA–PET in prostate cancer management Hit paper breakdown → | 2016 | 461 |
| 5 | 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies Hit paper breakdown → | 2015 | 419 |
| 6 | Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer Hit paper breakdown → | 2016 | 418 |
| 7 | Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer Hit paper breakdown → | 2016 | 280 |
| 8 | Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls Hit paper breakdown → | 2018 | 266 |
| 9 | Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy Hit paper breakdown → | 2018 | 248 |
| 10 | 2017 | 221 | |
| 11 | E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET Hit paper breakdown → | 2021 | 214 |
| 12 | 2016 | 188 | |
| 13 | 2015 | 179 | |
| 14 | 2017 | 178 | |
| 15 | 2018 | 168 | |
| 16 | 2016 | 165 | |
| 17 | 2017 | 163 | |
| 18 | 2016 | 158 | |
| 19 | 2016 | 153 | |
| 20 | 2016 | 153 |
About Matthias Eiber
Matthias Eiber is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Rheumatology and Cancer Research, having authored 189 papers that have together received 10.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (155 papers), Radiopharmaceutical Chemistry and Applications (101 papers), Prostate Cancer Diagnosis and Treatment (95 papers), Urologic and reproductive health conditions (23 papers), Medical Imaging Techniques and Applications (22 papers), Peptidase Inhibition and Analysis (14 papers), Cancer, Lipids, and Metabolism (10 papers) and Radiomics and Machine Learning in Medical Imaging (10 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (6.8k citations), Pulmonary and Respiratory Medicine (8.9k citations), Rheumatology (1.3k citations), Oncology (2.1k citations) and Cancer Research (1.0k citations). Matthias Eiber has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Tobias Maurer, Markus Schwaiger, Jürgen E. Gschwend, Hans‐Jürgen Wester, Isabel Rauscher, Ambros J. Beer, Michael Souvatzoglou, Bernhard Haller, Matthias Heck and Gregor Weirich. Their work appears in journals such as Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, EJNMMI Research, European Urology and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.